BIO-FD&C Co.,Ltd. (KOSDAQ:251120)

Market Cap	77.13B -47.4%
Revenue (ttm)	18.85B +13.6%
Net Income	6.20B +22.7%
EPS	726.16 +22.7%
Shares Out	8.70M
PE Ratio	12.21
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,884
Open	8,150.00
Previous Close	8,150.00
Day's Range	7,640.00 - 8,300.00
52-Week Range	7,640.00 - 22,650.00
Beta	0.29
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About BIO-FD&C

BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, natural extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, acne, skin irritation, wound healing, scalp improvement, skin moisturizing, fine dust, hair loss improvement, pores, lifting, whitening, skin texture, anti-inflammation/skin soothing, and anti-oxidation. The company was founded in 2005 and is headquartered in Incheon, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2005
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 251120

Financial Performance

In 2025, BIO-FD&C's revenue was 19.18 billion, an increase of 19.37% compared to the previous year's 16.07 billion. Earnings were 6.67 billion, an increase of 48.11%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 29, 2026

Data Sources Report a data error